Minocycline-induced drug hypersensitivity syndrome;Syndrome d'hypersensibilite a la minocycline

Annales de Dermatologie et de Venereologie

Volumn 126, Issue 6-7, 1999, Pages 518-521

  Antunes, A ^a   Davril, A ^a   Trechot P ^b   Grandidier, M ^a   Truchetet, F ^a   Cuny, J F ^a  

^a Centre Hospitalier Regional Metz Thionville   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; PETROLATUM; PREDNISONE; ANTIINFECTIVE AGENT;

ACNE; ADOLESCENT; ARTHRALGIA; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HUMAN; LOEFFLER PNEUMONIA; LYMPHADENOPATHY; PRICK TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; TOPICAL DRUG ADMINISTRATION; DRUG ERUPTION; PATHOLOGY; SKIN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; MINOCYCLINE; SKIN;

EID: 0032877526     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. : Minocycline induced autoimmune hepatitis and systemic lupus erythematous-like syndrome. BMJ 1996;312:169-72.
2. Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S. : Minocycline-related lupus. Lancet 1992;340:1553.
3. Quilty B, McHugh N. Lupus-like syndrome associated with the use of minocycline. Br J Rheum 1994;33:1197-8.
4. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Arch Dermatol 1996;132:934-9.
5. Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998;105:484-7.
6. Puyana J, Urena V, Quirce S, Fernandez-Rivas M, Cuevas M, Fraj J. Serum sickness-like syndrome associated with minocycline therapy. Allergy 1990;45:313-5.
7. Bonnetblanc JM. Drug hypersensitivity syndrome. Dermatology 1993; 187:84-5.
8. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
9. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985;40:111-8.
10. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms, DRESS). Semin Cutan Med Surg 1996;15:250-7.
11. Bonnetblanc JM. Le syndrome d'hypersensibilité médicamenteuse : à la recherche de son identité. Ann Dermatol Venereol 1998;125:309-10.
12. Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991;127:1361-4.
13. Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ 1989;298:1523-4.
14. Parneix-Spake A, Bastuji-Garin S, Lobut JB, Erner J, Guyet-Rousset P, Revuz J, Roujeau JC. Minocycline as possible cause of severe and protacted hypersensitivity drug reaction. Arch Dermatol 1995;131:490-1.
15. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P et al. Drug-induced pseudolymphoma and hypersensitivity syndrome: two different clinical entities. Arch Dermatol 1996;132:1315-21.
16. Bénéton N, Bocquet H, Callot V, Parneix A, Roujeau JC, Revuz J. Syndrome d'hypersensibilité à la minocycline. Ann Dermatol Venereol 1996;123 (Suppl 1) : 69-70.
17. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997;133:1224-30.
18. Stibon O, Bidel N, Dussopt C, Azarian R, Braud ML, Lebargy F et al. Minocycline pneumonitis and eosinophilia. Arch Intern Med 1994;154: 1633-40.
19. Bando T, Fujimara M, Noda Y., Hirose J, Ohta G, Matsuda T. Minocycline-induced pneumonitis with bilateral hilar lymphadenopathy and pleural effusion. Intern Med 1994;33:177-9.
20. Kohno S, Yamaguchi K, Yasuoka A, Koga H, Hayashi T, Komori K, Hara K. Clinical evaluation of 12 cases of antimicrobial drug-induced pneumonitis. Jpn J Med 1990;29:248-54.
21. Dykhuizen RS, Legge JS. Minocycline induced pulmonary eosinophilia. Respir Med 1995;89:61-2.
22. Dykhuizen RS, Zaidi AM, Godden DJ, Jegarajah S, Legge JS. Minocycline and pulmonary eosinophilia. BMJ 1995;310:1520-1.
23. Dussopt C, Mornex JF, Cordier JF, Brune J. Poumon éosinophile aigu après prise de minocycline. Rev Mal Resp 1994;11:67-70.
24. Guillon JM, Joly P, Autran B, Denis M, Akoun G, Debré P, Mayaud C. Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med 1992;117:476-81.
25. Yokoyama A, Mizushima Y, Suzuki H, Arai N, Kitagawa M, Yano S. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive re-challenge test. Jpn J Med 1990;29:195-8.
26. Min DI, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy 1992; 12:68-71.
27. Wilkinson SP, Stewart WK, Spiers EM, Pears J. Protacted systemic illness and interstitial nephritis due to minocyclin. Postgrad Med J 1989;65:53-6.
28. Calkin JM, Maibach HI. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993;29:223-33.
29. Barbaud A, Reichert-Penetrat S, Tréchot P, Jacquin-Petit MA, Ehlinger A, Noirez V et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
30. Bénéton N, Bocquet H, Cosnes A, Revuz J, Roujeau JC. Benefit-risk assessment of acne therapies. Lancet 1997;347:1251-2.